Ampligen Combined With SOC Versus SOC Alone Following First-Line Therapy in Subjects With LAPC
- Status
- SUSPENDED
- Phase
- PHASE2
Clinical Trials Related to Pancreatic Cancer
Related studies linked through entity extraction aliases.
The PLATON Network
- Status
- TERMINATED
- Phase
- N/A
Feasibility of a Health Care Provider Guided Exercise Intervention Prior to Surgical Resection of Pancreatic Cancer
- Status
- COMPLETED
- Phase
- NA
Clinical Study of CLDN18.2-targeting CAR T Cells in Advanced Solid Tumors With Positive CLDN18.2 Expression
- Status
- RECRUITING
- Phase
- PHASE1
PAncreas Borderline and Locally Advanced Snapshot Study
- Status
- UNKNOWN
- Phase
- N/A
Modulation of the Gut Microbiome With Pembrolizumab Following Chemotherapy in Resectable Pancreatic Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Intestinal Microbiome, Oral Microbiome, and Whole Blood Transcriptome Analyses in Gastrointestinal Malignancies
- Status
- COMPLETED
- Phase
- N/A
Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx)
- Status
- COMPLETED
- Phase
- N/A
A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Durvalumab and Tremelimumab in Combination With Propranolol and Chemotherapy for Treatment of Advanced Hepatopancreabiliary Tumors (BLOCKED)
- Status
- RECRUITING
- Phase
- PHASE2
Early Supportive Care and Nutritional Support in Adults With Pancreatic Cancer
- Status
- COMPLETED
- Phase
- NA
TCR-T Cell Therapy on Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- EARLY_PHASE1
GAIA-102 Intraperitoneal Administration in Patients With Advanced Gastrointestinal Cancer of Microsatellite Stable With Malignant Ascites
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Is One Pass Enough for the Diagnosis of the Pancreatic Masses During EUS-FNB?
- Status
- UNKNOWN
- Phase
- N/A
Phase I Study of ZN-c3 and Bevacizumab ± Pembrolizumab in Metastatic CCNE1 Amplified and TP53 Mutant Solid Tumors
- Status
- WITHDRAWN
- Phase
- PHASE1
Evaluating the Potential Usefulness of 18F-AlF-FAPI PET/CT in Patients With Gastrointestinal Tumors and Compared With 18F-FDG PET/CT
- Status
- COMPLETED
- Phase
- NA
Incremental Value of Magnetic Resonance Imaging in Selection of Pancreatic Cancer Patients for Surgery
- Status
- RECRUITING
- Phase
- NA
Combined Exercise and Nutritional Intervention in GI Cancer Patients
- Status
- RECRUITING
- Phase
- NA
Switch Maintenance in Pancreatic
- Status
- SUSPENDED
- Phase
- PHASE1/PHASE2
Adjuvant Gemcitabine and Capecitabine Chemotherapy in Resected Pancreatic Cancer Following Neoadjuvant Chemotherapy
- Status
- WITHDRAWN
- Phase
- PHASE2